MENU
NGENF
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION
NervGen Pharma (NGENF) Ownership - Who owns NervGen Pharma?
NervGen Pharma Corp is a clinical-stage biotech company... Show more
Profile
Industry
N/A
Address
112-970 Burrard Street
Phone
+1 778 731-1711
Employees
N/A
Web
https://www.nervgen.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
196.84M
P/E Ratio
N/A
Total Cash
14.55M
Projected Growth
N/A
Total Debt
81.84K
Revenue
N/A
Risk (Beta)
1.60
Dividend Yield
N/A
Total Cash/Share
0.20
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
NGENF
Capitalization
197M
P/E Ratio
N/A
Risk (Beta)
1.60
Dividend Yield
N/A
Total Cash
14.6M
Total Cash/Share
0.20
Total Debt
81.8K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
1.39M
P/B Ratio
192.31
Cash Flow
N/A
Earnings
-0.38
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
82.4M
Current Ratio
1.06
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-25.94M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-107.55
Shares Held By Institutions
0
Shares Outstanding - Current
71.9M
Total Liabilities
14.4M
Total Volume MTD
N/A
Value
-1
Gain YTD
25.229
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
112-970 Burrard Street
Phone
+1 778 731-1711
Employees
N/A
Web
https://www.nervgen.com